{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T09:37:57Z","timestamp":1772530677459,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jmgm.2026.109288","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T17:13:39Z","timestamp":1768324419000},"page":"109288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Repurposing drugs for EGFR-targeted cancer therapy: An in silico and in vitro study with pharmacophore-based insights"],"prefix":"10.1016","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1192-9416","authenticated-orcid":false,"given":"P\u0131nar","family":"Siyah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6401-686X","authenticated-orcid":false,"given":"Firat Baris","family":"Barlas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2026.109288_bib1","doi-asserted-by":"crossref","DOI":"10.1158\/1541-7786.MCR-23-0411","article-title":"Updating the definition of cancer","volume":"21","author":"Brown","year":"2023","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jmgm.2026.109288_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-021-01213-z","article-title":"Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990\u20132019","volume":"14","author":"Lin","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jmgm.2026.109288_bib3","doi-asserted-by":"crossref","unstructured":"A. Jemal, M. M. Center, C. DeSantis, E. M. Ward, 2010, DOI: 10.1158\/1055-9965.EPI-10-0437.","DOI":"10.1158\/1055-9965.EPI-10-0437"},{"key":"10.1016\/j.jmgm.2026.109288_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2017-000285","article-title":"Global cancer control: responding to the growing burden, rising costs and inequalities in access","volume":"3","author":"Prager","year":"2018","journal-title":"ESMO Open"},{"key":"10.1016\/j.jmgm.2026.109288_bib5","doi-asserted-by":"crossref","unstructured":"C. Sarkar, B. Das, V. S. Rawat, J. B. Wahlang, A. Nongpiur, I. Tiewsoh, N. M. Lyngdoh, D. Das, M. Bidarolli, H. T. Sony, 2023, DOI: 10.3390\/ijms24032026.","DOI":"10.3390\/ijms24032026"},{"key":"10.1016\/j.jmgm.2026.109288_bib6","doi-asserted-by":"crossref","unstructured":"V. Patel, M. Shah, 2022, DOI: 10.1016\/j.imed.2021.10.001.","DOI":"10.1016\/j.imed.2021.10.001"},{"key":"10.1016\/j.jmgm.2026.109288_bib7","series-title":"Paclitaxel: Sources, Chemistry, Anticancer Actions","author":"Chandraprasad","year":"2021"},{"key":"10.1016\/j.jmgm.2026.109288_bib8","doi-asserted-by":"crossref","unstructured":"M. O. Palumbo, P. Kavan, W. H. Miller, L. Panasci, S. Assouline, N. Johnson, V. Cohen, F. Patenaude, M. Pollak, R. T. Jagoe, G. Batist, 2013, DOI: 10.3389\/fphar.2013.00057.","DOI":"10.3389\/fphar.2013.00057"},{"key":"10.1016\/j.jmgm.2026.109288_bib9","doi-asserted-by":"crossref","DOI":"10.20517\/2394-4722.2017.35","article-title":"Cancer immunity and therapy using hyperthermia with immunotherapy, radiotherapy, chemotherapy, and surgery","volume":"3","author":"Yagawa","year":"2017","journal-title":"J. Cancer Metastasis Treat"},{"key":"10.1016\/j.jmgm.2026.109288_bib10","doi-asserted-by":"crossref","unstructured":"S. Gavas, S. Quazi, T. M. Karpi\u0144ski, 2021, DOI: 10.1186\/s11671-021-03628-6.","DOI":"10.1186\/s11671-021-03628-6"},{"key":"10.1016\/j.jmgm.2026.109288_bib11","doi-asserted-by":"crossref","unstructured":"R. Sinha, G. J. Kim, S. Nie, D. M. Shin, 2006, DOI: 10.1158\/1535-7163.MCT-06-0141.","DOI":"10.1158\/1535-7163.MCT-06-0141"},{"key":"10.1016\/j.jmgm.2026.109288_bib12","doi-asserted-by":"crossref","unstructured":"E. Hern\u00e1ndez-Lemus, M. Mart\u00ednez-Garc\u00eda, 2021, DOI: 10.3389\/fonc.2020.605680.","DOI":"10.3389\/fonc.2020.605680"},{"key":"10.1016\/j.jmgm.2026.109288_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2015.09.067","article-title":"Novel delivery approaches for cancer therapeutics","volume":"219","author":"Mitra","year":"2015","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.jmgm.2026.109288_bib14","doi-asserted-by":"crossref","unstructured":"D. Vemula, P. Jayasurya, V. Sushmitha, Y. N. Kumar, V. Bhandari, 2023, DOI: 10.1016\/j.ejps.2022.106324.","DOI":"10.1016\/j.ejps.2022.106324"},{"key":"10.1016\/j.jmgm.2026.109288_bib15","doi-asserted-by":"crossref","DOI":"10.1007\/s44254-023-00047-x","article-title":"Anesthetic drug discovery with computer-aided drug design and machine learning","volume":"2","author":"Liu","year":"2024","journal-title":"Anesthesiol. Perioper. Sci."},{"key":"10.1016\/j.jmgm.2026.109288_bib16","doi-asserted-by":"crossref","unstructured":"X. Pan, X. Lin, D. Cao, X. Zeng, P. S. Yu, L. He, R. Nussinov, F. Cheng, 2022, DOI: 10.1002\/wcms.1597.","DOI":"10.1002\/wcms.1597"},{"key":"10.1016\/j.jmgm.2026.109288_bib17","doi-asserted-by":"crossref","unstructured":"L. Zhao, H. L. Ciallella, L. M. Aleksunes, H. Zhu, 2020, DOI: 10.1016\/j.drudis.2020.07.005.","DOI":"10.1016\/j.drudis.2020.07.005"},{"key":"10.1016\/j.jmgm.2026.109288_bib18","doi-asserted-by":"crossref","unstructured":"T. Zubair, D. Bandyopadhyay, 2023, DOI: 10.3390\/ijms24032651.","DOI":"10.3390\/ijms24032651"},{"key":"10.1016\/j.jmgm.2026.109288_bib19","doi-asserted-by":"crossref","unstructured":"G. Lurje, H. J. Lenz, 2010, DOI: 10.1159\/000279388.","DOI":"10.1159\/000279388"},{"key":"10.1016\/j.jmgm.2026.109288_bib20","doi-asserted-by":"crossref","unstructured":"K. S. Alharbi, M. A. Javed Shaikh, O. Afzal, A. S. Alfawaz Altamimi, W. H. Almalki, S. I. Alzarea, I. Kazmi, F. A. Al-Abbasi, S. K. Singh, K. Dua, G. Gupta, 2022, DOI: 10.1016\/j.cbi.2022.110108.","DOI":"10.1016\/j.cbi.2022.110108"},{"key":"10.1016\/j.jmgm.2026.109288_bib21","doi-asserted-by":"crossref","unstructured":"A. M. Elshazly, D. A. Gewirtz, 2022, DOI: 10.20517\/cdr.2022.09.","DOI":"10.20517\/cdr.2022.09"},{"key":"10.1016\/j.jmgm.2026.109288_bib22","doi-asserted-by":"crossref","unstructured":"P. Seshacharyulu, M. P. Ponnusamy, D. Haridas, M. Jain, A. K. Ganti, S. K. Batra, 2012, DOI: 10.1517\/14728222.2011.648617.","DOI":"10.1517\/14728222.2011.648617"},{"key":"10.1016\/j.jmgm.2026.109288_bib23","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1039\/D2MD00105E","article-title":"Novel etodolac derivatives as eukaryotic elongation factor 2 kinase (eEF2K) inhibitors for targeted cancer therapy","volume":"13","author":"Onder","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109288_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129370","article-title":"Checking the STEP-associated trafficking and internalization of glutamate receptors for reduced cognitive deficits: a machine learning approach-based cheminformatics study and its application for drug repurposing","volume":"10","author":"Jamal","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jmgm.2026.109288_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jmgm.2026.109288_bib26","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1021\/acs.jctc.8b01026","article-title":"OPLS3e: extending force field coverage for drug-like small molecules","volume":"15","author":"Roos","year":"2019","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2026.109288_bib27","doi-asserted-by":"crossref","unstructured":"D. Giordano, C. Biancaniello, M. A. Argenio, A. Facchiano, 2022, DOI: 10.3390\/ph15050646.","DOI":"10.3390\/ph15050646"},{"key":"10.1016\/j.jmgm.2026.109288_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpj.2022.11.942","article-title":"Discovery of potential PD-L1 small molecule inhibitors as novel cancer therapeutics using machine learning-based QSAR models: a virtual drug repurposing study","volume":"122","author":"Siyah","year":"2023","journal-title":"Biophys. J."},{"key":"10.1016\/j.jmgm.2026.109288_bib29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/prot.10613","article-title":"A hierarchical approach to all\u2010atom protein loop prediction","volume":"55","author":"Jacobson","year":"2004","journal-title":"Proteins: Struct., Funct., Bioinf."},{"key":"10.1016\/j.jmgm.2026.109288_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113566","article-title":"New nimesulide derivatives with amide\/sulfonamide moieties: Selective COX-2 inhibition and antitumor effects","volume":"221","author":"G\u00fcng\u00f6r","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109288_bib31","doi-asserted-by":"crossref","first-page":"W32","DOI":"10.1093\/nar\/gku293","article-title":"SwissTargetPrediction: a web server for target prediction of bioactive small molecules","volume":"42","author":"Gfeller","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2026.109288_bib32","doi-asserted-by":"crossref","first-page":"W357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2026.109288_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202400343","article-title":"Innovative fluorescent polymers in niosomal carriers: a novel approach to enhancing cancer therapy and imaging","author":"Tornaci","year":"2024","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jmgm.2026.109288_bib34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/bs.pmch.2021.01.004","article-title":"Use of molecular docking computational tools in drug discovery","volume":"60","author":"Stanzione","year":"2021","journal-title":"Prog. Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109288_bib35","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/cbdd.13084","article-title":"Aromatic interactions at the ligand\u2013protein interface: implications for the development of docking scoring functions","volume":"91","author":"Brylinski","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jmgm.2026.109288_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.insi.2025.100048","article-title":"Mechanistic insights into the allosteric inhibition of EGFR by dibenzodiazepinone DDC4002: a molecular dynamics, binding free energy, conformational motions and thermodynamic landscape approach","author":"Ahmad","year":"2025","journal-title":"Silico Res. Biomed."},{"key":"10.1016\/j.jmgm.2026.109288_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202501410","article-title":"Discovery of novel dual EGFR\/HER2 inhibitors using integrated docking, molecular dynamics, and MMGBSA computational approaches","volume":"10","author":"El Mehdi","year":"2025","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.jmgm.2026.109288_bib38","doi-asserted-by":"crossref","first-page":"21452","DOI":"10.1039\/D2RA03451D","article-title":"Molecular docking and dynamics based approach for the identification of kinase inhibitors targeting PI3K\u03b1 against non-small cell lung cancer: a computational study","volume":"12","author":"Halder","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.jmgm.2026.109288_bib39","doi-asserted-by":"crossref","first-page":"16307","DOI":"10.1021\/acsomega.0c02183","article-title":"Molecular dynamics analysis of binding sites of epidermal growth factor receptor kinase inhibitors","volume":"5","author":"Li","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.jmgm.2026.109288_bib40","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1007\/s00044-014-1072-3","article-title":"Quantitative structure\u2013activity relationship (QSAR) studies as strategic approach in drug discovery","volume":"23","author":"Patel","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jmgm.2026.109288_bib41","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.drudis.2016.06.013","article-title":"Descriptors and their selection methods in QSAR analysis: paradigm for drug design","volume":"21","author":"Khan","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jmgm.2026.109288_bib42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.jmgm.2026.109288_bib43","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jmgm.2026.109288_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jics.2022.100601","article-title":"Investigation of novel compounds via in silico approaches of EGFR inhibitors as anticancer agents","volume":"99","author":"T\u00fcrkmeno\u011flu","year":"2022","journal-title":"J. Indian Chem. Soc."},{"key":"10.1016\/j.jmgm.2026.109288_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102956","article-title":"Exploration of N-alkyl-2-[(4-oxo-3-(4-sulfamoylphenyl)-3,4-dihydroquinazolin-2-yl)thio]acetamide derivatives as anticancer and radiosensitizing agents","volume":"88","author":"Soliman","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jmgm.2026.109288_bib46","doi-asserted-by":"crossref","first-page":"28608","DOI":"10.1039\/D4RA04165H","article-title":"Design and evaluation of sulfadiazine derivatives as potent dual inhibitors of EGFR WT and EGFR T790M: integrating biological, molecular docking, and ADMET analysis","volume":"14","author":"Abd El-Lateef","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.jmgm.2026.109288_bib47","doi-asserted-by":"crossref","unstructured":"M. N. Abdullah, Y. Ali, S. Abd Hamid, 2022, DOI: 10.1111\/cbdd.13974.","DOI":"10.1111\/cbdd.13974"},{"key":"10.1016\/j.jmgm.2026.109288_bib48","doi-asserted-by":"crossref","DOI":"10.1007\/s00044-014-1090-1","article-title":"In silico molecular docking study of natural compounds on wild and mutated epidermal growth factor receptor","volume":"23","author":"Singh","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.jmgm.2026.109288_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.30160","article-title":"A novel cyclic NP1 reveals obstruction of EGFR kinase activity and attenuation of EGFR-driven cell lines","volume":"123","author":"Jiwacharoenchai","year":"2022","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jmgm.2026.109288_bib50","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.1c01714","article-title":"Development of dual inhibitors targeting epidermal growth factor receptor in cancer therapy","volume":"65","author":"Tan","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109288_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdc.2021.100741","article-title":"Siswandono, \u201cIn silico study of 1-benzoyl-3-methylthiourea derivatives activity as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor candidates\u201d","volume":"34","author":"Ruswanto","year":"2021","journal-title":"Chem. Data Collect."},{"key":"10.1016\/j.jmgm.2026.109288_bib52","doi-asserted-by":"crossref","first-page":"251","DOI":"10.32552\/2022.ActaMedica.737","article-title":"In silico activity and target prediction analyses of three triazolothiadiazine derivatives","volume":"53","author":"Sucularl\u0131","year":"2022","journal-title":"Acta Med."},{"key":"10.1016\/j.jmgm.2026.109288_bib53","first-page":"1","article-title":"Identification of natural product as selective PI3K\u03b1 inhibitor against NSCLC: multi-ligand pharmacophore modeling, molecular docking, ADME, DFT, and MD simulations","author":"Halder","year":"2023","journal-title":"Mol. Divers."},{"key":"10.1016\/j.jmgm.2026.109288_bib54","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/s41598-023-28821-8","article-title":"Identifying molecular targets of Aspiletrein-derived steroidal saponins in lung cancer using network pharmacology and molecular docking-based assessments","volume":"13","author":"Iksen","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2026.109288_bib55","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.2147\/DDDT.S350913","article-title":"A potent EGFR inhibitor, N-phenyl pyrazoline derivative suppresses aggressiveness and cancer stem cell-like phenotype of cervical cancer cells","author":"Mustofa","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.jmgm.2026.109288_bib56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/cells13010047","article-title":"Targeted inhibitors of EGFR: structure, biology, biomarkers, and clinical applications","volume":"13","author":"Shaban","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.jmgm.2026.109288_bib57","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1002\/cam4.881","article-title":"Erlotinib induces the human non\u2013small\u2010cell lung cancer cells apoptosis via activating ROS\u2010dependent JNK pathways","volume":"5","author":"Shan","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.jmgm.2026.109288_bib58","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jmgm.2026.109288_bib59","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s40203-023-00157-1","article-title":"In-silico identification of small molecule benzofuran-1, 2, 3-triazole hybrids as potential inhibitors targeting EGFR in lung cancer via ligand-based pharmacophore modeling and molecular docking studies","volume":"11","author":"Kumar","year":"2023","journal-title":"Silico Pharmacol."},{"key":"10.1016\/j.jmgm.2026.109288_bib60","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4103\/1735-5362.245963","article-title":"Exploring the interaction between epidermal growth factor receptor tyrosine kinase and some of the synthesized inhibitors using combination of in-silico and in-vitro cytotoxicity methods","volume":"13","author":"Nasab","year":"2018","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.jmgm.2026.109288_bib61","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1177\/09603271211030554","article-title":"EGFR tyrosine kinase inhibitor Almonertinib induces apoptosis and autophagy mediated by reactive oxygen species in non-small cell lung cancer cells","volume":"40","author":"Ge","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.jmgm.2026.109288_bib62","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4161\/cbt.11.12.15693","article-title":"Autophagy inhibition cooperates with erlotinib to induce glioblastoma cell death","volume":"11","author":"Eimer","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.jmgm.2026.109288_bib63","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1440-1681.2008.05091.x","article-title":"Erlotinib activates mitochondrial death pathways related to the production of reactive oxygen species in the human non\u2010small cell lung cancer cell line A549","volume":"36","author":"Qian","year":"2009","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.jmgm.2026.109288_bib64","unstructured":"O. Elaskalani, A. Domenichini, N. B. Abdol Razak, F. M. D Ed, P. Metharom, n.d."},{"key":"10.1016\/j.jmgm.2026.109288_bib65","unstructured":"F. Vieceli Dalla Sega, F. Fortini, G. Aquila, R. Pavasini, S. Biscaglia, D. Bernucci, A. Del Franco, E. Tonet, P. Rizzo, R. Ferrari, 2018."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326000148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326000148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:16:53Z","timestamp":1772525813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326326000148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":65,"alternative-id":["S1093326326000148"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109288","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing drugs for EGFR-targeted cancer therapy: An in silico and in vitro study with pharmacophore-based insights","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109288"}}